Both in Biotechnology
Iovance Biotherapeutics vs Denali Therapeutics
Over the past year IOVA returned +330.5% and DNLI returned +16.3%; their daily moves had a correlation of 0.27.
IOVA +330.5% DNLI +16.3%Growth of $1, one year, split-adjusted
| Metric | IOVA | DNLI |
|---|---|---|
| Price | $8.48 | $18.94 |
| Market cap | $3.84B | $3.03B |
| Today | −11.30% | −1.97% |
| 1 month | −40.4% | −7.7% |
| 6 months | +149.4% | +3.5% |
| Year to date | +210.6% | +14.7% |
| 1 year | +324.0% | +16.6% |
| Revenue growth (YoY) | +65.7% | — |
| Gross margin | 56.1% | 97.4% |
| Net margin | −47.6% | −3539.2% |
| P/E (TTM) | — | — |
| Price / sales | 11.8× | 840.0× |
| Net cash | $297.7M | $705.0M |
| Dividend yield | — | — |
| Volatility (60d) | 128.2% | 37.4% |
| Short % of float | 15.2% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).